Drreddys Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
ANI Pharmaceuticals USD 217.8M 67.99M 2025-06
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bayer EUR 4.56B 542M 2025-06
Canopy Growth CAD 16.31M 69.8M 2024-12
Cipla INR 8B 1.22B 2025-03
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Drreddys Laboratories INR 1.1B 743M 2024-12
GlaxoSmithKline GBP 3.6B 865M 2025-06
Hikma Pharmaceutical USD 188M 188M 2024-12
Lonza CHF 1.11B 286M 2024-12
Novartis USD 6.66B 410M 2025-06
Pacira USD 300.48M 16.87M 2025-06
Prestige Brands USD 139.5M 41.62M 2025-06
Richter Gedeon HUF 135.63B 61.59B 2024-12
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
Teva Pharmaceutical Industries USD 2.16B 464M 2025-06


Drreddys Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.